I will call it conservative if the trials are successful and they publish a good statistical outcome.
In any case I agree 3 x Phase 2 successful result is a fair estimate for these market conditions.
However given the potential and that there aren't many direct competitors the MC should be sitting a lot higher than $120M
I will call it conservative if the trials are successful and...
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.006(5.71%) |
Mkt cap ! $89.25M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.9¢ | $35.68K | 354.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 196446 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 238249 | 4 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |